Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Chromatography Reagents Market to Reach $7,609.3 Million by 2018

Published: Thursday, August 29, 2013
Last Updated: Thursday, August 29, 2013
Bookmark and Share
The global chromatography reagents market is segmented on the basis of application, technique, end users, and geography.

The application market is further classified into analytical chromatography reagents and bio-process/preparative chromatography reagents.

The “Chromatography Reagents Market By Type [Alkylation, Acylation, Solvent, Buffer], Bed Shape [Column, Thin layer], Mobile Phase [HPLC, UHPLC, HILIC, Flash, SFC], Separation Mechanism [Adsorption, Partition, Affinity] & End User - Global Forecasts to 2018”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

This report studies the global chromatography reagents market over the forecast period of 2013-2018. The market is estimated at $4,598.0 million in 2013 and is poised to grow at a CAGR of 10.6% from 2013 to 2018, to reach $7,609.3 million by 2018.

The global chromatography reagents market is categorized into three broad segments, namely, by type, by technique, and by end user. The chromatography reagents market by type is broadly categorized intosilylation reagents, alkylation reagents, acylation reagents, ion-pairing reagents, solvents, buffers, and solid support for analytical applications.

Chromatography reagents market by type for bioprocess/preparative applications is broadly categorized into solvents, buffers, and solid support. The chromatography reagents market by technique is categorized into column and planar chromatography reagents based on bed shape; gas, liquid, and supercritical phase chromatography reagents based on physical state of mobile phase; and adsorption, partition, ion-exchange, size exclusion, and affinity chromatography reagents based on separation mechanism.

End users of the chromatography reagents are pharmaceutical, biopharmaceutical & biotechnology industries, academics/government/research, food and beverage industries, hospitals/clinics, cosmetics industries, environmental agencies, nutraceutical companies, and others.

North America is the largest chromatography reagents market. The large size of the North American chromatography reagents market can be attributed to augmented research activities for the development of drugs and biologics, increasing number of conferences, and growth in government investments.

Increasing conferences on chromatography in Singapore and Malaysia; expansion of chromatography companies in China, India, Singapore, Vietnam, and Japan; prominent pharmaceutical companies outsourcing their drug discovery and development services to Asian (especially in China and India) are the factors that are fueling the demand for separation services and chromatography reagents in Asia.

The major players in the chromatography reagents market include Agilent Technologies (U.S.),Waters Corporation(U.S.), EMD/Merck Millipore (U.S.), Phenomenex, Inc. (U.S.), Sigma- Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories (U.S.), G.E Healthcare (U.K.),Tosoh Corporation (Japan),Pall Corporation (U.S.), Life Technologies (U.S.), VWR International LLC.(U.S.), W.R. Grace & Co.(U.S.), Becton Dickinson & Co (U.S.), Regis Technologies (U.S.), and Helena Laboratories (U.S.).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos